These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 803722)

  • 1. Recent advances and controversies in the management of Hodgkin's disease.
    O'Brien PH; Wallace K; Rambo VB
    Surg Gynecol Obstet; 1975 Mar; 140(3):445-51. PubMed ID: 803722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hodgkin's disease: classification, staging, therapy].
    Wewerka JR
    Schweiz Med Wochenschr; 1978 Aug; 108(32):1241-6. PubMed ID: 150029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
    Berkowicz M; Rath P; Aghai E; Many A; Ben-Bassat I; Hulu N; Ramot B; Brenner H
    Isr J Med Sci; 1978 Dec; 14(12):1275-82. PubMed ID: 748241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Hodgkin's disease.
    Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laparotomy in the therapy of Hodgkin's disease].
    Bauters F; Jouet JP; Caulier MT; Wurtz A; Ribet M; Goudemand M
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):495-502. PubMed ID: 917838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenectomy effects on chemotherapy in Hodgkin's disease.
    Panettiere F; Coltman CA
    Arch Intern Med; 1973 Mar; 131(3):362-6. PubMed ID: 4688035
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
    Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
    NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 11. International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
    Kaplan HS; Rosenberg SA
    Natl Cancer Inst Monogr; 1973 May; 36():363-71. PubMed ID: 4582994
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
    Diehl LF; Perry DJ; Terebelo H; Baldwin PE; Hurwitz M; Kimball DB; Dorn RV
    Cancer Treat Rep; 1983 Sep; 67(9):827-9. PubMed ID: 6883360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Hodgkin's disease stages I, II, and III].
    Teillet F; Bayle-Weisgerber C; Andrieu JM
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):485-94. PubMed ID: 917837
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
    Tubiana M; Mathé G
    Ser Haematol; 1973; 6(2):202-43. PubMed ID: 4206180
    [No Abstract]   [Full Text] [Related]  

  • 16. Current trend in the treatment of Hodgkin's disease.
    Tubiana M; Amiel JL; Hayat M; Henry-Amar M; Cosset JM; Droz JP; Carde P
    Radiat Med; 1983; 1(3):221-9. PubMed ID: 6390537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH
    N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    De Lena M; Monfardini S; Beretta G; Fossati-Bellani F; Bonadonna G
    Natl Cancer Inst Monogr; 1973 May; 36():403-20. PubMed ID: 4126720
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM; Asselain B; Bayle C; Teillet F; Clot P; Dana M; Katz M; Brière J; Jacquillat C; Bernard J
    Bull Cancer; 1981; 68(2):190-9. PubMed ID: 7016225
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation.
    Lancet; 1976 Nov; 2(7993):991-5. PubMed ID: 62265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.